Jonathan Riess, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Daiichi Sankyo
    Topic:
    Advisory Board
    Date added:
    10/15/2022
    Date updated:
    04/17/2025
    Relationship end date:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    Advisory Board
    Date added:
    04/23/2024
    Date updated:
    04/17/2025
    Relationship end date:
    07/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Catalyst
    Topic:
    Advisory Board
    Date added:
    04/23/2024
    Date updated:
    04/17/2025
    Relationship end date:
    10/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    SeaGen
    Topic:
    Advisory Board
    Date added:
    04/23/2024
    Date updated:
    04/17/2025
    Relationship end date:
    02/22/2023
Return to 2025 San Francisco Lung Cancer Conference